Plateauing atrial fibrillation burden in acute ischemic stroke admissions in the United States from 2010 to 2020.

IF 6.3 2区 医学 Q1 CLINICAL NEUROLOGY International Journal of Stroke Pub Date : 2024-06-01 Epub Date: 2024-01-02 DOI:10.1177/17474930231222163
Fadar Oliver Otite, Smit D Patel, Ehimen Aneni, Oluwatomi Lamikanra, Claribel Wee, Karen C Albright, Devin Burke, Julius Gene Latorre, Nicholas Allen Morris, Nnabuchi Anikpezie, Amit Singla, Ashish Sonig, Hooman Kamel, Priyank Khandelwal, Seemant Chaturvedi
{"title":"Plateauing atrial fibrillation burden in acute ischemic stroke admissions in the United States from 2010 to 2020.","authors":"Fadar Oliver Otite, Smit D Patel, Ehimen Aneni, Oluwatomi Lamikanra, Claribel Wee, Karen C Albright, Devin Burke, Julius Gene Latorre, Nicholas Allen Morris, Nnabuchi Anikpezie, Amit Singla, Ashish Sonig, Hooman Kamel, Priyank Khandelwal, Seemant Chaturvedi","doi":"10.1177/17474930231222163","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Utilization of oral anticoagulants for acute ischemic stroke (AIS) prevention in patients with atrial fibrillation (AF) increased in the United States over the last decade. Whether this increase has been accompanied by any change in AF prevalence in AIS at the population level remains unknown. The aim of this study is to evaluate trends in AF prevalence in AIS hospitalizations in various age, sex, and racial subgroups over the last decade.</p><p><strong>Methods: </strong>We used data contained in the 2010-2020 National Inpatient Sample to conduct a serial cross-sectional study. Primary AIS hospitalizations with and without comorbid AF were identified using International Classification of Diseases Codes. Joinpoint regression was used to compute annualized percentage change (APC) in prevalence and to identify points of change in prevalence over time.</p><p><strong>Results: </strong>Of 5,190,148 weighted primary AIS hospitalizations over the study period, 25.1% had comorbid AF. The age- and sex-standardized prevalence of AF in AIS hospitalizations increased across the entire study period 2010-2020 (average APC: 1.3%, 95% confidence interval (CI): 0.8-1.7%). Joinpoint regression showed that prevalence increased in the period 2010-2015 (APC: 2.8%, 95% CI: 1.9-3.9%) but remained stable in the period 2015-2020 (APC: -0.3%, 95% CI: -1.0 to 1.9%). Upon stratification by age and sex, prevalence increased in all age/sex groups from 2010 to 2015 and continued to increase throughout the entire study period in hospitalizations in men 18-39 years (APC: 4.0%, 95% CI: 0.2-7.9%), men 40-59 years (APC: 3.4%, 95% CI: 1.9-4.9%) and women 40-59 years (APC: 4.4%, 95% CI: 2.0-6.8%). In contrast, prevalence declined in hospitalizations in women 60-79 (APC: -1.0%, 95% CI: -0.5 to -1.5%) and women ⩾ 80 years over the period 2015-2020 but plateaued in hospitalizations in similar-aged men over the same period.</p><p><strong>Conclusion: </strong>AF prevalence in AIS hospitalizations in the United States increased over the period 2010-2015, then plateaued over the period 2015-2020 due to declining prevalence in hospitalizations in women ⩾ 60 years and plateauing prevalence in hospitalizations in men ⩾ 60 years.</p>","PeriodicalId":14442,"journal":{"name":"International Journal of Stroke","volume":" ","pages":"547-558"},"PeriodicalIF":6.3000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Stroke","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17474930231222163","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Utilization of oral anticoagulants for acute ischemic stroke (AIS) prevention in patients with atrial fibrillation (AF) increased in the United States over the last decade. Whether this increase has been accompanied by any change in AF prevalence in AIS at the population level remains unknown. The aim of this study is to evaluate trends in AF prevalence in AIS hospitalizations in various age, sex, and racial subgroups over the last decade.

Methods: We used data contained in the 2010-2020 National Inpatient Sample to conduct a serial cross-sectional study. Primary AIS hospitalizations with and without comorbid AF were identified using International Classification of Diseases Codes. Joinpoint regression was used to compute annualized percentage change (APC) in prevalence and to identify points of change in prevalence over time.

Results: Of 5,190,148 weighted primary AIS hospitalizations over the study period, 25.1% had comorbid AF. The age- and sex-standardized prevalence of AF in AIS hospitalizations increased across the entire study period 2010-2020 (average APC: 1.3%, 95% confidence interval (CI): 0.8-1.7%). Joinpoint regression showed that prevalence increased in the period 2010-2015 (APC: 2.8%, 95% CI: 1.9-3.9%) but remained stable in the period 2015-2020 (APC: -0.3%, 95% CI: -1.0 to 1.9%). Upon stratification by age and sex, prevalence increased in all age/sex groups from 2010 to 2015 and continued to increase throughout the entire study period in hospitalizations in men 18-39 years (APC: 4.0%, 95% CI: 0.2-7.9%), men 40-59 years (APC: 3.4%, 95% CI: 1.9-4.9%) and women 40-59 years (APC: 4.4%, 95% CI: 2.0-6.8%). In contrast, prevalence declined in hospitalizations in women 60-79 (APC: -1.0%, 95% CI: -0.5 to -1.5%) and women ⩾ 80 years over the period 2015-2020 but plateaued in hospitalizations in similar-aged men over the same period.

Conclusion: AF prevalence in AIS hospitalizations in the United States increased over the period 2010-2015, then plateaued over the period 2015-2020 due to declining prevalence in hospitalizations in women ⩾ 60 years and plateauing prevalence in hospitalizations in men ⩾ 60 years.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2010-2020 年美国急性缺血性中风住院病人心房颤动负担趋于平稳。
背景:过去十年间,美国心房颤动(AF)患者使用口服抗凝药预防急性缺血性卒中(AIS)的人数有所增加。这一增长是否伴随着人群水平上 AIS 中房颤患病率的变化仍是未知数。本研究旨在评估过去十年间不同年龄、性别和种族亚群的 AIS 住院患者中房颤患病率的变化趋势:我们使用 2010-2020 年全国住院病人样本中的数据开展了一项连续横断面研究。我们使用国际疾病分类代码确定了有无合并房颤的原发性 AIS 住院病例。连接点回归用于计算患病率的年化百分比变化(APC),并确定患病率随时间变化的点:结果:在研究期间,5,190,148 例加权初级 AIS 住院病例中,25.1% 合并房颤。在 2010-2020 年整个研究期间,AIS 住院病例中按年龄和性别标准化的房颤患病率有所上升(平均 APC 为 1.3%,95%CI 为 0.8% 至 1.7%)。连接点回归显示,2010-2015 年期间患病率有所上升(APC:2.8%,95%CI 1.9% 至 3.9%),但在 2015-2020 年期间保持稳定(APC:-0.3%,95%CI -1.0% 至 1.9%)。按年龄和性别分层后,2010-2015 年期间,所有年龄/性别组的患病率均有所上升,并且在整个研究期间,18-39 岁男性(APC:4.0%,95%CI 0.2% 至 7.9%)、40-59 岁男性(APC:3.4%,95%CI 1.9% 至 4.9%)和 40-59 岁女性(APC:4.4%,95%CI 2.0% 至 6.8%)的住院率持续上升。相比之下,2015-2020年期间,60-79岁女性(APCv-1.0%,95%CI -0.5%至-1.5%)和≥80岁女性的住院患病率有所下降,但同期年龄相仿的男性住院患病率则趋于平稳:结论:2010-2015年期间,美国AIS住院患者中房颤患病率有所上升,随后在2015-2020年期间趋于平稳,原因是≥60岁女性住院患者中房颤患病率下降,而≥60岁男性住院患者中房颤患病率趋于平稳。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Stroke
International Journal of Stroke 医学-外周血管病
CiteScore
13.90
自引率
6.00%
发文量
132
审稿时长
6-12 weeks
期刊介绍: The International Journal of Stroke is a welcome addition to the international stroke journal landscape in that it concentrates on the clinical aspects of stroke with basic science contributions in areas of clinical interest. Reviews of current topics are broadly based to encompass not only recent advances of global interest but also those which may be more important in certain regions and the journal regularly features items of news interest from all parts of the world. To facilitate the international nature of the journal, our Associate Editors from Europe, Asia, North America and South America coordinate segments of the journal.
期刊最新文献
Impact of time from symptom onset to puncture, and puncture to reperfusion, in endovascular therapy in the late time window (>6 h). International practice patterns and perspectives on endovascular therapy for the treatment of cerebral venous thrombosis. Prehospital blood pressure lowering in patients with ischemic stroke: A systematic review and meta-analysis of randomized controlled trials. Stroke recurrence after transcatheter PFO closure in patients with cryptogenic stroke. Advancing stroke safety and efficacy through early tirofiban administration after intravenous thrombolysis: The multicenter, randomized, placebo-controlled, double-blind ASSET IT trial protocol.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1